Investigating the role of IGF-1 in diabetic gastroparesis: a preliminary review
Acta Diabetologica · 24.10.2025 · 63 (1) · 163-170
DOI: 10.1007/s00592-025-02578-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Diabetologica, online erschienen am 24.10.2025. Verfasst von Yifan Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, P.R. C…. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Gastroparesis, Diabetes Complications, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: the Fatty Liver clinical medicine innovation center of integrated traditional Chinese and Western medicine.
Abstract (Originalsprache)
Diabetic gastroparesis is characterized by delayed gastric emptying due to diabetes mellitus, affecting up to 50% of patients with type 1 and type 2 diabetes who have poor glycemic control, significantly impairing their quality of life. IGF-1 presents significant potential as a therapeutic target for DGP due to its neuroprotective effects and its role in inhibiting smooth muscle cell apoptosis. By promoting the survival and regeneration of interstitial cells of Cajal and reducing inflammation, IGF-1 could enhance gastrointestinal regulation, thereby improving gastric motility and alleviating DGP symptoms. Although IGF-1 has not yet been utilized as a targeted therapy for DGP, its ability to modulate key signaling pathways, such as SCF/C-Kit, PI3K/AKT, and ERK/MAPK, suggests promising therapeutic avenues. Future research should focus on investigating these mechanisms to determine IGF-1's precise role in DGP pathophysiology and explore its clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, P.R. China.
- Department of Endocrinology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210000, Jiangsu, China.
- The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210000, Jiangsu, China.
- School of Nursing, Nanjing University of Chinese Medicine, Nanjing, China.
- State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, P.R. China. qbwu@must.edu.mo.
- Department of Endocrinology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210000, Jiangsu, China. zhouxiqiao@njucm.edu.cn.
Förderung
- the Fatty Liver clinical medicine innovation center of integrated traditional Chinese and Western medicine
Zitieren
APA
Lu, Y., Wei, W., Chen, H., Xie, Y., Tian, J., Zhao, Z., Wu, Q., & Zhou, X. (2025). Investigating the role of IGF-1 in diabetic gastroparesis: a preliminary review. Acta Diabetologica, 63(1), 163-170. https://doi.org/10.1007/s00592-025-02578-0
Vancouver
Lu Y, Wei W, Chen H, Xie Y, Tian J, Zhao Z, et al. Investigating the role of IGF-1 in diabetic gastroparesis: a preliminary review. Acta Diabetologica. 2025;63(1):163-170. doi:10.1007/s00592-025-02578-0
BibTeX
@article{Lu2025,
author = {Lu, Yifan and Wei, Wei and Chen, Hao and Xie, Yixuan and Tian, Jie and Zhao, Ziming and Wu, Qibiao and Zhou, Xiqiao},
title = {Investigating the role of IGF-1 in diabetic gastroparesis: a preliminary review},
journal = {Acta Diabetologica},
year = {2025},
volume = {63},
number = {1},
pages = {163--170},
doi = {10.1007/s00592-025-02578-0}
}
EUVIMED